Bank of America’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.7M Buy
121,812
+29,251
+32% +$4.02M ﹤0.01% 2370
2025
Q1
$16.7M Buy
92,561
+16,762
+22% +$3.02M ﹤0.01% 2284
2024
Q4
$11.9M Sell
75,799
-28,855
-28% -$4.52M ﹤0.01% 2357
2024
Q3
$19.1M Buy
104,654
+11,025
+12% +$2.01M ﹤0.01% 2102
2024
Q2
$17.2M Buy
93,629
+17,785
+23% +$3.27M ﹤0.01% 2101
2024
Q1
$13.5M Sell
75,844
-15,349
-17% -$2.73M ﹤0.01% 2288
2023
Q4
$11.3M Buy
91,193
+27,968
+44% +$3.47M ﹤0.01% 2300
2023
Q3
$7.33M Buy
63,225
+20,455
+48% +$2.37M ﹤0.01% 2556
2023
Q2
$5.02M Sell
42,770
-50,117
-54% -$5.88M ﹤0.01% 2878
2023
Q1
$7.44M Buy
92,887
+24,844
+37% +$1.99M ﹤0.01% 2659
2022
Q4
$5.39M Buy
68,043
+26,679
+64% +$2.11M ﹤0.01% 2844
2022
Q3
$2.88M Buy
41,364
+2,627
+7% +$183K ﹤0.01% 3347
2022
Q2
$2.54M Sell
38,737
-3,858
-9% -$253K ﹤0.01% 3520
2022
Q1
$2.83M Buy
42,595
+29,386
+222% +$1.96M ﹤0.01% 3663
2021
Q4
$924K Buy
13,209
+6,099
+86% +$427K ﹤0.01% 4644
2021
Q3
$370K Sell
7,110
-1,100
-13% -$57.2K ﹤0.01% 5054
2021
Q2
$558K Buy
8,210
+2,360
+40% +$160K ﹤0.01% 4626
2021
Q1
$451K Buy
5,850
+1,321
+29% +$102K ﹤0.01% 4839
2020
Q4
$272K Sell
4,529
-509
-10% -$30.6K ﹤0.01% 4691
2020
Q3
$218K Sell
5,038
-632
-11% -$27.3K ﹤0.01% 4652
2020
Q2
$235K Sell
5,670
-4,975
-47% -$206K ﹤0.01% 4597
2020
Q1
$461K Buy
10,645
+5,412
+103% +$234K ﹤0.01% 4041
2019
Q4
$290K Sell
5,233
-7,713
-60% -$427K ﹤0.01% 4629
2019
Q3
$449K Buy
12,946
+7,269
+128% +$252K ﹤0.01% 4419
2019
Q2
$229K Sell
5,677
-39
-0.7% -$1.57K ﹤0.01% 4816
2019
Q1
$188K Buy
5,716
+5,530
+2,973% +$182K ﹤0.01% 4829
2018
Q4
$3K Buy
186
+166
+830% +$2.68K ﹤0.01% 6060
2018
Q3
$0 Buy
+20
New ﹤0.01% 6547